No immediate trading catalyst — this is a routine equity plan replenishment and annual LTIP grant. The increased share reserve signals management's intent to continue equity compensation, but the dilution is modest (~4.5%). Monitor the May 2026 proxy (filed April 9) for additional context on compensation targets and comparator group. The 82.7% shareholder approval for the LTIP plan is routine but slightly below the 90%+ threshold seen at some peers — watch for any follow-up activist or governance engagement.
Price Chart
Executive Summary
Regional Management Corp. filed an 8-K reporting the re-approval of its 2024 Long-Term Incentive Plan (amended to increase share reserve from 381,000 to 813,014 shares) and the grant of LTIP awards to named executive officers, including $3.32M in total PRSUs and restricted stock. All director nominees were elected and Deloitte ratified as auditor at the May 14, 2026 annual meeting. This is a routine annual equity plan replenishment and compensatory grant filing with no material financial surprise.
Key Facts
- Share reserve under the LTIP increased from 381,000 to 813,014 shares (adds 432,014 new shares) as re-approved by stockholders.
- LTIP awards granted to NEOs: CEO Lamba received $2.5M (50% PRSU, 50% restricted stock); CFO Rana $1.0M; other NEOs aggregate $1.14M; total NEO grants = $4.64M.
- PRSUs vest based on TSR vs comparator group and pre-provision ROA over a 3-year performance period (2026-2029); restricted stock vests in three equal annual tranches through Dec 2028.
- All 9 director nominees elected with >92% support; Deloitte ratified as auditor with 98.5% approval; LTIP re-approval passed with 82.7% of votes cast (excluding broker non-votes).
- Say-on-pay advisory vote passed with 89.8% support.
- Stockholders voted 7,897,395 for, 19,961 against to ratify Deloitte as auditor for FY2026.
Financial Impact
Equity incentive plan dilution capped at ~432,014 new shares (representing approximately $13.8M at implied $32/share market price, or ~4.5% dilution relative to ~9.6M shares outstanding). Annual NEO grant cost ~$1.5-1.6M per year recognized over vesting schedule.
Risk Factors
- Potential overhang from equity plan dilution if share price stagnates.
- PRSU performance targets depend on TSR ranking and pre-provision ROA; weak credit cycle could impair payout.
- Insider selling activity (5 sells totaling $1.1M in past 30 days) may indicate management hedging, though likely routine.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-230932 |
| Document: 0001193125-26-230932-index.html | 0001193125-26-230932 |
| Document: 0001193125-26-230932.txt | 0001193125-26-230932 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 16, 2026 5w ago | 8-K | $32.10 $34.47 | ▲ +7.38% | ▲ +5.93% | $32.54 (+1.37%) |
Aug 13, 2026 10w ago | Insider Buy | $33.50 $32.90 | ▼ −1.79% | ▲ +0.20% | $32.54 (−2.87%) |
May 19, 2026 22w ago | 8-K | $34.96 $37.20 | ▲ +6.41% | ▲ +5.67% | $32.54 (−6.92%) |
Apr 15, 2026 27w ago | Insider Cluster | $38.22 $34.25 | ▲ +10.39% | ▲ +16.43% | $32.54 (+14.86%) |
Apr 15, 2026 27w ago | Insider Cluster | $38.22 $34.25 | ▲ +10.39% | ▲ +16.43% | $32.54 (+14.86%) |
Apr 15, 2026 27w ago | Insider Cluster | $38.22 $34.25 | ▲ +10.39% | ▲ +16.43% | $32.54 (+14.86%) |
Apr 15, 2026 27w ago | Insider Cluster | $38.22 $34.25 | ▲ +10.39% | ▲ +16.43% | $32.54 (+14.86%) |
Mar 5, 2026 33w ago | 8-K | $32.24 $34.23 | ▲ +6.17% | ▲ +8.22% | $32.54 (+0.93%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers